Possible Rivaroxaban Failure during the Postpartum Period: An Alternative Viewpoint

被引：0
作者：
Bond, Alison M. [1 ,2 ]
Bartle, Bill [1 ,2 ]
Rudd, Kelly M. [3 ]
Winans, Amanda R. McFee [3 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Thromboembolism & Anticoagulat Management Team, 2075 Bayview Ave,Room E233, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Bassett Med Ctr, Cooperstown, NY USA
来源：
PHARMACOTHERAPY | 2016年 / 36卷 / 04期
关键词：
Rivaroxaban; Venous Thromboembolism; Failure; VENOUS THROMBOEMBOLISM; RISK-FACTORS; PREGNANCY; ASSAY;
D O I：
10.1002/phar.1736
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E26 / E27
页数：2
相关论文
共 11 条
  • [1] Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
    Barrett, Yu Chen
    Wang, Zhaoqing
    Frost, Charles
    Shenker, Andrew
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) : 1263 - 1271
  • [2] Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
    Bauersachs, Rupert
    Berkowitz, Scott D.
    Brenner, Benjamin
    Buller, Harry R.
    Decousus, Herve
    Gallus, Alex S.
    Lensing, Anthonie W.
    Misselwitz, Frank
    Prins, Martin H.
    Raskob, Gary E.
    Segers, Annelise
    Verhamme, Peter
    Wells, Phil
    Agnelli, Giancarlo
    Bounameaux, Henri
    Cohen, Alexander
    Davidson, Bruce L.
    Piovella, Franco
    Schellong, Sebastian
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) : 2499 - 2510
  • [3] Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
    Douketis, JD
    Kearon, C
    Bates, S
    Duku, EK
    Ginsberg, JS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06): : 458 - 462
  • [4] Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy
    Douketis, JD
    Foster, GA
    Crowther, MA
    Prins, MH
    Ginsberg, JS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (22) : 3431 - 3436
  • [5] Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study
    Heit, JA
    Kobbervig, CE
    James, AH
    Petterson, TM
    Bailey, KR
    Melton, LJ
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (10) : 697 - 706
  • [6] Population pharmacokinetics and pharmacodynamics of rivaroxaban -: An oral, direct factor Xa inhibitor in patients undergoing major orthopaedic surgery
    Mueck, Wolfgang
    Eriksson, Bengt I.
    Bauer, Kenneth A.
    Borris, Lars
    Dahl, Ola E.
    Fisher, William D.
    Gent, Michael
    Haas, Sylvia
    Huisman, Menno V.
    Kakkar, Ajay K.
    Kalebo, Peter
    Kwong, Louis M.
    Misselwitz, Frank
    Turpie, Alexander G. G.
    [J]. CLINICAL PHARMACOKINETICS, 2008, 47 (03) : 203 - 216
  • [7] Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study
    Pomp, E. R.
    Lenselink, A. M.
    Rosendaal, F. R.
    Doggen, C. J. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (04) : 632 - 637
  • [8] Possible Rivaroxaban Failure during the Postpartum Period
    Rudd, Kelly M.
    Winans, Amanda R. McFee
    Panneerselvam, Narmadha
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E164 - E168
  • [9] An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma
    Samama, Meyer Michel
    Amiral, Jean
    Guinet, Celine
    Perzborn, Elisabeth
    Depasse, Francois
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 104 (05) : 1078 - 1079
  • [10] Obesity as a risk factor in venous thromboembolism
    Stein, PD
    Beernath, A
    Olson, RE
    [J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 (09) : 978 - 980
12